Triamcinolone acetonide with lidocaine
Preclinical
Triamcinolone acetonide with lidocaine is one of 10 therapeutic programs targeting Tenosynovitis. It is currently in Preclinical.
1
Indications
1
Total Trials
0
Active Trials
9
Competitors
Pipeline
Status by Indication[2][1]
Indication
Competition
Competitive Landscape
9 competitors in Tenosynovitis
#DrugCompanyPhaseTrials
1Medrol
PfizerApproved
Celestone
SSchering-Plough
Approved
Deltasone
PPfizer's Upjohn has merged with Mylan to form Viatris Inc.
Approved
Decadron
AAspen Global Incorporated
Approved
Kenalog
BBausch Health Americas, Inc.
Approved
Rayos
RRoxane Laboratories
Approved
Cortef
PPfizer's Upjohn has merged with Mylan to form Viatris Inc.
Approved
Xylocaine
MMEDRx USA, Inc.
Preclinical
Decadron
QQuince Therapeutics S.p.A.
Preclinical
Triamcinolone acetonide with lidocaine
RRawalpindi Teaching Hospital, District Headquarter Hospital, Rawalpindi
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]
Details
Drug Info
Quick Facts
- Highest Phase
- Preclinical[1]